Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (356) 356
Publication (35) 35
Patent (21) 21
Conference Proceeding (4) 4
Dissertation (3) 3
Book Review (2) 2
Magazine Article (2) 2
Streaming Audio (2) 2
Book Chapter (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (65) 65
female (41) 41
male (41) 41
life sciences (33) 33
index medicus (32) 32
middle aged (29) 29
immunology (26) 26
adult (22) 22
infectious diseases (21) 21
analysis (20) 20
hiv (20) 20
pharmacology & pharmacy (20) 20
psychology, applied (17) 17
animals (16) 16
psychology (16) 16
flow cytometry (14) 14
humanities and social sciences (14) 14
career counseling (13) 13
hiv infection (13) 13
aged (12) 12
research (12) 12
personality (11) 11
acraeinae (10) 10
amlodipine (10) 10
antihypertensive agents - therapeutic use (10) 10
efficacy (10) 10
expression (10) 10
law (10) 10
microbiology (10) 10
santé publique et épidémiologie (10) 10
therapy (10) 10
adolescent (9) 9
amlodipine - therapeutic use (9) 9
electricity (9) 9
health aspects (9) 9
human immunodeficiency virus--hiv (9) 9
lepidoptera (9) 9
nymphalidae (9) 9
prevention (9) 9
psychology, multidisciplinary (9) 9
treatment outcome (9) 9
virology (9) 9
virus diseases (9) 9
viruses (9) 9
amlodipine - adverse effects (8) 8
cells, cultured (8) 8
hiv infections - drug therapy (8) 8
hypertension - drug therapy (8) 8
infections (8) 8
microbiology and parasitology (8) 8
monocytes - immunology (8) 8
risk (8) 8
[sdv.spee]life sciences [q-bio]/santé publique et épidémiologie (7) 7
acquired immune deficiency syndrome--aids (7) 7
acraea (7) 7
aids (7) 7
blood pressure - drug effects (7) 7
chemical sciences (7) 7
cohort (7) 7
constitutional law (7) 7
engineering, civil (7) 7
france (7) 7
hematology (7) 7
human immunodeficiency virus (7) 7
hypertension (7) 7
in-vitro (7) 7
monocytes - cytology (7) 7
patients (7) 7
prospective studies (7) 7
risk factors (7) 7
behavior (6) 6
biochemistry & molecular biology (6) 6
blasting (6) 6
career development (6) 6
cd4 antigen (6) 6
cell biology (6) 6
dendritic cells (6) 6
dogs (6) 6
double-blind method (6) 6
engineering, geological (6) 6
finite element method (6) 6
heating (6) 6
hiv patients (6) 6
human health and pathology (6) 6
labor law (6) 6
lighting (6) 6
mechanical engineering (6) 6
methods (6) 6
mortality (6) 6
pathology (6) 6
physics (6) 6
physiological aspects (6) 6
questionnaire (6) 6
weapons (6) 6
[ sdv.spee ] life sciences [q-bio]/santé publique et épidémiologie (5) 5
activation (5) 5
adaptive counseling (5) 5
adults (5) 5
anti-hiv agents - therapeutic use (5) 5
antibodies, monoclonal (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?
by Pradat, P and Pugliese, P and Poizot-Martin, I and Valantin, MA and Cuzin, L and Reynes, J and Billaud, E and Huleux, T and Bani-Sadr, F and Rey, D and Fresard, A and Jacomet, C and Duvivier, C and Cheret, A and Hustache-Mathieu, L and Hoen, B and Cabie, A and Cotte, L and Dat'AIDS Study Grp and Dat'AIDS study Group
JOURNAL OF INFECTION, ISSN 0163-4453, 09/2017, Volume 75, Issue 3, pp. 234 - 241
Objectives: Direct-Acting Antivirals (DAAs) opened a new era in HCV treatment. We report the impact of HCV treatment in French HIV-HCV coinfected patients.... 
MORTALITY | INFECTIOUS DISEASES | Coinfection | Treatment uptake | DAA | Direct acting antiviral agent | SEX | HUMAN-IMMUNODEFICIENCY-VIRUS | Epidemiology | FRANCE | HIV | MEN | HCV | COHORT | Hepatitis C - drug therapy | Coinfection - drug therapy | HIV Infections - epidemiology | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | Hepatitis C, Chronic - complications | Hepatitis C Antibodies - blood | Hepatitis C - epidemiology | Female | Hepatitis C - complications | Hepatitis C, Chronic - epidemiology | Hepacivirus - drug effects | France - epidemiology | Antiviral Agents - therapeutic use | HIV Infections - virology | Genotype | Treatment Outcome | Coinfection - epidemiology | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Coinfection - virology | HIV Infections - complications | Hepatitis C - virology | Virus diseases | Antiviral agents | HIV patients | Drug therapy | Hepatitis C virus | HIV (Viruses) | Health aspects | HIV infection | Care and treatment
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Hepatitis C virus incidence in HIV‐infected and in preexposure prophylaxis (PrEP)‐using men having sex with men
by Cotte, Laurent and Cua, Eric and Reynes, Jacques and Raffi, François and Rey, David and Delobel, Pierre and Gagneux‐Brunon, Amandine and Jacomet, Christine and Palich, Romain and Laroche, Hélène and Cabie, André and Hoen, Bruno and Chidiac, Christian and Pradat, Pierre and Ferry, T and Ader, F and Biron, F and Boibieux, A and Miailhes, P and Perpoint, T and Valour, F and Schlienger, I and Lippmann, J and Braun, E and Koffi, J and Longuet, C and Guéripel, V and Augustin‐Normand, C and Brochier, C and Degroodt, S and Pugliese, P and Breaud, S and Ceppi, C and Courjon, J and Cottalorda, J and Cottalorda, J and Dellamonica, P and Demonchy, E and De Monte, A and Durant, J and Durant, J and Etienne, C and Etienne, C and Ferrando, S and Fuzibet, J. G and Garraffo, R and Joulie, A and Risso, K and Mondain, V and Naqvi, A and Oran, N and Perbost, I and Pillet, S and Prouvost‐Keller, B and Pradier, C and Wehrlen‐Pugliese, S and Rio, V and Rosenthal, E and Sausse, S and Zouzou, G and Brégigeon, S and Zaegel‐Faucher, O and Obry‐Roguet, V and Orticoni, M and Soavi, M. J and Ressiot, E and Carta‐Padovani, M and Ducassou, M. J and Jaquet, I and Galie, S and Galinier, A and Martinet, P and Landon, M and Ritleng, A. S and Ivanova, A and Blanco‐Betancourt, C and Debreux, C and Lions, C and Poizot‐Martin, I and Valantin, M. A and Caby, F and Tubiana, R and Agher, R and Seang, S and Schneider, L and Blanc, C and Katlama, C and Cheret, A and Goujard, C and Quertainmont, Y and Teicher, E and Lerolle, N and Vittecoq, D and Deradji, O and Fourreau, F and Pallier, C and Barrail‐Tran, A and Consigny, P. H and Cessot, G and Bossi, P and ... and Dat'AIDS Study Grp and Dat'AIDS study Group and The Dat'AIDS Study Group
Liver International, ISSN 1478-3223, 10/2018, Volume 38, Issue 10, pp. 1736 - 1740
Background & Aims HCV incidence still appears on the rise in HIV‐infected MSM in France. We assessed the incidence of HCV infection in HIV‐positive and in... 
HIV | preexposure prophylaxis | HCV incidence | men having sex with men | GASTROENTEROLOGY & HEPATOLOGY | Medical research | Medicine, Experimental | Hepatitis C virus | HIV (Viruses) | Drug therapy | Health aspects | HIV infection | Hepatitis | Sexually transmitted diseases | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Prophylaxis | Viruses | Infections | Hepatitis C | Health risk assessment | Patients | Incidence | Life Sciences | Santé publique et épidémiologie
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Hepatitis C treatment initiation in HIV-HCV coinfected patients
by Cotte, Laurent and Pugliese, Pascal and Valantin, Marc-Antoine and Cuzin, Lise and Billaud, Eric and Duvivier, Claudine and Naqvi, Alissa and Cheret, Antoine and Rey, David and Pradat, Pierre and Poizot-Martin, Isabelle and Raffi, F and Allavena, C and Billaud, E and Biron, C and Bonnet, B and Bouchez, S and Boutoille, D and Brunet, C and Jovelin, T and Hall, N and Bernaud, C and Morineau, P and Reliquet, V and Aubry, O and Point, P and Besnier, M and Larmet, L and Hüe, H and Pineau, S and André-Garnier, E and Rodallec, A and Brégigeon, S and Faucher, O and Obry-Roguet, V and Orticoni, M and Soavi, M.J and Luquet-Besson, I and Ressiot, E and Pinot, I and Ducassou, M.J and Bertone, H and Gallie, S and Trijau, S and Ritleng, A.S and Ivanova, A and Guignard, M and Blanco-Betancourt, C and Poizot-Martin, I and Marchou, B and Massip, P and Bonnet, E and Obadia, M and Alvarez, M and Porte, L and Cuzin, L and Delobel, P and Chauveau, M and Garipuy, D and Lepain, I and Marcel, M and Puntis, E and Sauné, K and Pugliese, P and Ceppi, C and Cua, E and Cottalorda, J and Dellamonica, P and Dat'AIDS Study Grp and Dat’AIDS study Group and the Dat’AIDS study Group
BMC Infectious Diseases, ISSN 1471-2334, 07/2016, Volume 16, Issue 1, p. 345
Background: There are few data regarding HCV treatment initiation among HIV/HCV coinfected patients. The objective of this study was to analyze the changing... 
Treatment initiation | HCV | Coinfection | HIV | Epidemiology | INFECTIOUS DISEASES | RISK | PREVALENCE | HUMAN-IMMUNODEFICIENCY-VIRUS | LIVER-RELATED DEATHS | INDIVIDUALS | OUTPATIENT | THERAPY | INFECTED PATIENTS | COHORT | HIV-1 | Liver Cirrhosis - drug therapy | France - epidemiology | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | Coinfection - drug therapy | Liver Cirrhosis - complications | HIV Infections - epidemiology | Humans | Risk Factors | Male | Coinfection - epidemiology | Liver Cirrhosis - epidemiology | Time Factors | Hepatitis C - epidemiology | Adult | Female | HIV Infections - drug therapy | Drug Therapy, Combination | Homosexuality, Male - statistics & numerical data | Hepacivirus | Complications and side effects | Antiviral agents | Research | Hepatitis C | Drug therapy | HIV infection | Health aspects | Risk factors | Infectious diseases | Life Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial
by Molina, Jean-Michel and Charreau, Isabelle and Chidiac, Christian and Pialoux, Gilles and Cua, Eric and Delaugerre, Constance and Capitant, Catherine and Rojas-Castro, Daniela and Fonsart, Julien and Bercot, Béatrice and Bébéar, Cécile and Cotte, Laurent and Robineau, Olivier and Raffi, François and Charbonneau, Pierre and Aslan, Alexandre and Chas, Julie and Niedbalski, Laurence and Spire, Bruno and Sagaon-Teyssier, Luis and Carette, Diane and Mestre, Soizic Le and Doré, Veronique and Meyer, Laurence and Pintado, C and Loze, B and Gatey, C and Ponscarme, D and Penot, P and Veron, R and Delgado, J and Dalle, E and Parlier, S and Madelaine, I and Danet, M and Mahjoub, N and Mezreb, N and Moudachirou, K and Morel, S and Conort, G and Lorho, F and Meunier, M and Rozenbaum, W and Monfort, C and Foucoin, J and Boissavy, B and Cousseau, S and Huon, S and Djessima, A and Berrebi, V and Adda, A and le Nagat, S and Zarka, L and Berdougo, J and Mzoughi, N and Clement, F and Decouty, A and Chapolard, C and Godinot, M and Adouard-groslafeige, C and Koffi, J and Pansu, A and Becker, A and Pailhes, S and Bonnet, F and Bonnet, B and Jeanblanc, F and Brochier, C and Teruin, X and Rouby, S and Gilly, L and Etienne, C and Tolonin, F and Breaud, S and Péchenot, V and Bagge, S and Cepitelli, T and Roger, PM and Rosenthal, E and Cheret, A and Cornavin, P and Vandamme, S and Lambec, J and Dumon, N and Leclanche, O and Huleux, T and Biekre, R and Melliez, H and Bazus, H and Pasquet, A and Bernaud, C and Besnier, M and Hall, N and Cavellec, M and Hue, H and Larmet, L and Colas, M and Choquet, R and Fouéré, S and Netzer, E and ... and ANRS IPERGAY Study Grp and ANRS IPERGAY Study Group
The Lancet Infectious Diseases, ISSN 1473-3099, 03/2018, Volume 18, Issue 3, pp. 308 - 317
Increased rates of sexually transmitted infections (STIs) have been reported among men who have sex with men. We aimed to assess whether post-exposure... 
INFECTIOUS DISEASES | MINOCYCLINE | DISEASES | EFFICACY | SAFETY | DEMAND PREEXPOSURE PROPHYLAXIS | HIGH-RISK | WORKERS | NEISSERIA-GONORRHOEAE | CHEMOPROPHYLAXIS | HIV-1 INFECTION | Doxycycline - therapeutic use | Humans | Middle Aged | Male | Sexually Transmitted Diseases - prevention & control | Young Adult | Anti-Bacterial Agents - therapeutic use | Doxycycline - administration & dosage | Homosexuality, Male | Adolescent | Post-Exposure Prophylaxis | Adult | Anti-Bacterial Agents - administration & dosage | Prevention | Sexually transmitted diseases | Disease transmission | Analysis | Doxycycline | Medicine, Preventive | Preventive health services | Leptospirosis | Sexually transmitted diseases--STD | Prophylaxis | Infections | Gonorrhea | Drug resistance | Disease prevention | Studies | Charities | Mens health | Chlamydia | Antibiotics | Acquired immune deficiency syndrome--AIDS | Surveillance | Human immunodeficiency virus--HIV | Syphilis | Sex industry | Condoms | Public health | Life Sciences | Santé publique et épidémiologie
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients – “En route for eradication”?
by Pradat, Pierre and Pugliese, Pascal and Poizot-Martin, Isabelle and Valantin, Marc-Antoine and Cuzin, Lise and Reynes, Jacques and Billaud, Eric and Huleux, Thomas and Bani-Sadr, Firouze and Rey, David and Frésard, Anne and Jacomet, Christine and Duvivier, Claudine and Cheret, Antoine and Hustache-Mathieu, Laurent and Hoen, Bruno and Cabié, André and Cotte, Laurent
Journal of Infection, ISSN 0163-4453, 2017, Volume 75, Issue 3, pp. 234 - 241
Summary Objectives Direct-Acting Antivirals (DAAs) opened a new era in HCV treatment. We report the impact of HCV treatment in French HIV-HCV coinfected... 
Infectious Disease | Coinfection | HIV | Treatment uptake | DAA | Direct acting antiviral agent | HCV | Epidemiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Risk of diabetes in HIV‐infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort
by Provoost, A and Dramé, M and Cotte, L and Cuzin, L and Garraffo, R and Rey, D and Raffi, F and Poizot‐Martin, I and Pugliese, P and Bani‐Sadr, F and Enel, P and Obry‐Roguet, V and Faucher, O and Bregigeon, S and Ménard, A and Poizot‐Martin, I and Alvarez, M and Biezunski, N and Cuzin, L and Debard, A and Delobel, P and Delpierre, C and Fourcade, C and Marchou, B and Martin‐Blondel, G and Porte, L and Mularczyk, M and Garipuy, D and Saune, K and Lepain, I and Marcel, M and Metsu, D and Puntis, E and Pugliese, P and Bentz, L and Ceppi, C and Cua, E and Cottalorda, J and Durant, J and Ferrando, S and Fuzibet, J. G and Garraffo, R and Mondain, V and Naqvi, A and Perbost, I and Pillet, S and Prouvost‐Keller, B and Pradier, C and Wehrlen‐Pugliese, S and Roger, P. M and Rosenthal, E and Dellamonica, P and Raffi, F and Allavena, C and Billaud, E and Biron, C and Bonnet, B and Bouchez, S and Boutoille, D and Khatchatourian, L and Brunet, C and Jovelin, T and Hall, N and Bernaud, C and Morineau, P and Reliquet, V and Aubry, O and Point, P and Besnier, M and Hüe, H and Cavellec, M and Soria, A and Sécher, S and André‐Garnier, E and Rodallec, A and Ferré, V and Leguen, L and Lefebvre, M and Grossi, O and Jacomet, C and Cheret, A and Choisy, P and Duvivier, C and Valantin, M. A and Agher, R and Katlama, C and Isnard‐Bagnis, C and Peytavin, G and Joly, V and Yazdanpanah, Y and Cabié, A and Abel, S and Pierre‐François, S and Liautaud, B and Rey, D and Fischer, P and Partisani, M and Cheneau, C and Priester, M and Bernard‐Henry, C and ... and Dat'AIDS Study Grp and Dat'AIDS study group and the Dat'AIDS study group
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 08/2018, Volume 48, Issue 3, pp. 281 - 289
Summary Background Both human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections have been reportedly associated with a higher risk of... 
SUSTAINED VIROLOGICAL RESPONSE | INSULIN-RESISTANCE | C VIRUS-INFECTION | ADULTS | PHARMACOLOGY & PHARMACY | MELLITUS | CHRONIC KIDNEY-DISEASE | LIVER-DISEASE | GASTROENTEROLOGY & HEPATOLOGY | TYPE-2 | CHRONIC VIRAL-HEPATITIS | INTERFERON THERAPY | Highly active antiretroviral therapy | Antiviral agents | Comorbidity | HIV patients | Diabetes | Hepatitis C virus | HIV (Viruses) | Hepatitis C | Health aspects | HIV infection | Liver cirrhosis | Risk factors | Therapy | Chronic infection | Viruses | Risk | Infections | Multivariate analysis | Hepatitis | Body mass index | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Antiretroviral drugs | Diabetes mellitus | Health risks | Patients | Antiretroviral therapy | CD4 antigen | Survival analysis | Cirrhosis | Body mass | Body size | Interferon
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study
by Gantner, P and Cuzin, L and Allavena, C and Cabie, A and Pugliese, P and Valantin, M‐A and Bani‐Sadr, F and Joly, V and Ferry, T and Poizot‐Martin, I and Garraffo, R and Peytavin, G and Fafi‐Kremer, S and Rey, D and Billaud, E and Biron, C and Bonnet, B and Bouchez, S and Boutoille, D and Brunet, C and Jovelin, T and Hall, N and Bernaud, C and Morineau, P and Reliquet, V and Aubry, O and Point, P and Besnier, M and Grossi, O and Lefebvre, M and Hüe, H and Cavellec, M and Soria, A and Pineau, S and André‐Garnier, E and Rodallec, A and Brégigeon, S and Faucher, O and Obry‐Roguet, V and Orticoni, M and Soavi, M. J and Luquet‐Besson, I and Ressiot, E and Pinot, I and Ducassou, M. J and Bertone, H and Gallie, S and Trijau, S and Ritleng, A. S and Ivanova, A and Guignard, M and Blanco‐Betancourt, C and Alvarez, M and Biezunski, N and Debard, A and Delobel, P and Delpierre, C and Fourcade, C and Marchou, B and Martin‐Blondel, G and Porte, L and Mularczyk, M and Garipuy, D and Saune, K and Lepain, I and Marcel, M and Puntis, E and Ceppi, C and Cua, E and Cottalorda, J and Dellamonica, P and Demonchy, E and Dunais, B and Durant, J and Etienne, C and Ferrando, S and Fuzibet, J. G and Risso, K and Mondain, V and Naqvi, A and Oran, N and Perbost, I and Pillet, S and Prouvost‐Keller, B and Pradier, C and Wehrlen‐Pugliese, S and Rosenthal, E and Sausse, S and Roger, P. M and Choisy, Ph and Vandame, S and Huleux, Th and Ajana, F and Alcaraz, I and Baclet, V and Huleux, T. H and Melliez, H and Viget, N and Valette, M and Aissi, E and ... and Dat'AIDS Study Grp and Dat'AIDS study group and on behalf of the Dat'AIDS study group
HIV Medicine, ISSN 1464-2662, 10/2017, Volume 18, Issue 9, pp. 704 - 708
TRIAL | INDIVIDUALS | INFECTIOUS DISEASES | MONOTHERAPY | PLASMA | RALTEGRAVIR | DOUBLE-BLIND | ANTIRETROVIRAL THERAPY | NAIVE ADULTS | INTEGRASE INHIBITORS | HIV-INFECTED PATIENTS | Anti-HIV Agents - pharmacology | HIV-1 - drug effects | Heterocyclic Compounds, 3-Ring - pharmacology | Humans | Middle Aged | Male | Treatment Outcome | Anti-HIV Agents - administration & dosage | Rilpivirine - pharmacology | Heterocyclic Compounds, 3-Ring - administration & dosage | Female | HIV Infections - drug therapy | Retrospective Studies | Drug Therapy, Combination | Rilpivirine - administration & dosage | Cohort Studies | Wine | Analysis | Life Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Reaching the Second and Third Joint United Nations Programme on HIV/AIDS 90-90-90 Targets Is Accompanied by a Dramatic Reduction in Primary Human Immunodeficiency Virus (HIV) Infection and in Recent HIV Infections in a Large French Nationwide HIV Cohort
by Le Guillou, Adrien and Pugliese, Pascal and Raffi, François and Cabie, André and Cuzin, Lise and Katlama, Christine and Allavena, Clotilde and Drame, Moustapha and Cotte, Laurent and Bani-Sadr, Firouzé and Orticoni, M and Soavi, M J and Luquet- Besson, I and Ressiot, E and Carta- Padovani, M and Ducassou, M J and Bertone, H and Galie, S and Galinier, A and Monclar, M and Ritleng, A S and Ivanova, A and Blanco-Betancourt, C and Lions, C and Poizot-Martin, I and Dhiver, C and Saadia Mokhtari, M and Ménard, A and Tissot Dupont, H and Toméi, C and Meddeb, L and Belkhir, A Y and Ravaux, I and Alvarez, M and Biezunski, N and Debard, A and Delpierre, C and Lansalot, P and Lelièvre, L and Martin-Blondel, G and Piffaut, M and Porte, L and Saune, K and Delobel, P and Pugliese, P and Breaud, S and Ceppi, C and Chirio, D and Cua, E and Dellamonica, P and Demonchy, E and De Monte, A and Durant, J and Etienne, C and Ferrando, S and Garraffo, R and Michelangeli, C and Mondain, V and Allavena, C and Bernaud, C and Billaud, E and Biron, C and Bonnet, B and Bouchez, S and Boutoille, D and Brunet-Cartier, C and Deschanvres, C and Gaborit, B and Hall, N and Jovelin, T and Le Turnier, P and Morineau, P and Reliquet, V and Sécher, S and Cavellec, M and Soria, A and Ferré, V and André-Garnier, E and Rodallec, A and Lefebvre, M and Grossi, O and Aubry, O and Raffi, F and Amazzough, K and Benabdelmoumen, G and Bossi, P and Cessot, G and Charlier, C and Consigny, P H and Danion, F and Dureault, A and Duvivier, C and Goesch, J and Guery, R and Henry, B and Jidar, K and Lanternier, F and Loubet, P and Lortholary, O and Louisin, C and ... and Dat’AIDS Study Group
Clinical Infectious Diseases, ISSN 1058-4838, 08/2019
Abstract Background In late 2013, France was one of the first countries to recommend initiation of combination antiretroviral therapy (cART) irrespective of... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: The road to elimination
by Virlogeux, Victor and Zoulim, Fabien and Pugliese, Pascal and Poizot-Martin, Isabelle and Valantin, Marc-Antoine and Cuzin, Lise and Reynes, Jacques and Billaud, Eric and Huleux, Thomas and Bani-Sadr, Firouze and Rey, David and Frésard, Anne and Jacomet, Christine and Duvivier, Claudine and Cheret, Antoine and Hustache-Mathieu, Laurent and Hoen, Bruno and Cabié, André and Cotte, Laurent and Chidiac, C and Ferry, T and Ader, F and Biron, F and Boibieux, A and Miailhes, P and Perpoint, T and Schlienger, I and Lippmann, J and Braun, E and Koffi, J and Longuet, C and Guéripel, V and Augustin-Normand, C and Brochier, C and Degroodt, S and Pugliese, Pascal and Ceppi, C and Cua, E and Cottalorda, J and Courjon, J and Dellamonica, P and Demonchy, E and De Monte, A and Durant, J and Etienne, C and Ferrando, S and Fuzibet, J.G and Garraffo, R and Joulie, A and Risso, K and Mondain, V and Naqvi, A and Oran, N and Perbost, I and Pillet, S and Prouvost-Keller, B and Wehrlen-Pugliese, S and Rosenthal, E and Sausse, S and Rio, V and Roger, P.M and Brégigeon, S and Faucher, O and Obry-Roguet, V and Orticoni, M and Soavi, M.J and de Lamarlière, P. Geneau and Laroche, H and Ressiot, E and Carta, M and Ducassou, M.J and Jacquet, I and Gallie, S and Galinier, A and Ritleng, A.S and Ivanova, A and Blanco-Betancourt, C and Lions, C and Debreux, C and Obry-Roguet, V and Agher, R and Katlama, C and Lortholary, O and Lanternier, F and Charlier, C and Rouzaud, C and Aguilar, C and Henry, B and Lebeaux, D and Cessot, G and Gergely, A and Consigny, P.H and Touam, F and Louisin, C and Alvarez, M and Biezunski, N and Debard, A and Delobel, P and Delpierre, C and Fourcade, C and ... and Dat'AIDS Study Grp and Dat’AIDS Study Group and the Dat’AIDS Study Group
BMC Medicine, ISSN 1741-7015, 12/2017, Volume 15, Issue 1, pp. 217 - 11
Background: HCV treatment uptake has drastically increased in HIV-HCV coinfected patients in France since direct-acting antiviral (DAA) treatment approval,... 
Compartmental model | Coinfection | HCV elimination | HIV | Treatment uptake | Direct-acting antiviral agent | HCV | Mathematical modeling | MSM | RISK | SEXUAL TRANSMISSION | MEDICINE, GENERAL & INTERNAL | HEPATITIS-C VIRUS | INFECTED PATIENTS | COHORT | GLOBAL EPIDEMIOLOGY | PREEXPOSURE PROPHYLAXIS | REINFECTION INCIDENCE | POSITIVE MEN | Physiological aspects | HIV patients | Care and treatment | Diagnosis | Hepatitis C | Prevalence studies (Epidemiology) | Life Sciences | Santé publique et épidémiologie
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Ageing with HIV: do comorbidities and polymedication drive treatment optimization?
by Cuzin, L and Katlama, C and Cotte, L and Pugliese, P and Cheret, A and Bernaud, C and Rey, D and Poizot‐Martin, I and Chirouze, C and Bani‐Sadr, F and Cabié, A and Brégigeon, S and Zaegel‐Faucher, O and Obry‐Roguet, V and Orticoni, M and Soavi, M. J and Luquet‐Besson, I and Ressiot, E and Carta‐ Padovani, M and Ducassou, M. J and Bertone, H and Galie, S and Galinier, A and Monclar, M and Martinet, P and Ritleng, A. S and Ivanova, A and Blanco‐Betancourt, C and Lions, C and Marchou, B and Massip, P and Obadia, M and Alvarez, M and Porte, L and Delobel, P and Martin‐Blondel, G and Debard, A and Chauveau, M and Garipuy, D and Mularczyk, M and Bernard, J and Labau, E and Lepain, I and Marcel, M and Puntis, E and Sauné, K and Ceppi, C and Cua, E and Cottalorda, J and Dellamonica, P and Demonchy, E and Dunais, B and Durant, J and Etienne, C and Ferrando, S and Fuzibet, J. G and Garraffo, R and Risso, K and Mondain, V and Naqvi, A and Oran, N and Perbost, I and Pillet, S and Prouvost‐Keller, B and Pradier, C and Wehrlen‐Pugliese, S and Rosenthal, E and Sausse, S and Roger, P. M and Allavena, C and Billaud, E and Biron, C and Bonnet, B and Bouchez, S and Boutoille, D and Brunet‐Cartier, C and Hall, N and Jovelin, T and Morineau, P and Raffi, F and Reliquet, V and Hue, H and Larmet, L and Pineau, S and Ferré, V and André‐Garnier, E and Rodallec, A and Vivrel, F and Lefebvre, M and Grossi, O and Point, P and Aubry, O and Choisy, P and Yazdanpanah, Y and Landman, R and Duvivier, C and Valantin, M. A and Agher, R and Lortholary, O and Avettand‐Fenoel, V and ... and Dat'AIDS Study Grp and Dat'AIDS Study Group and the Dat'AIDS Study Group
HIV Medicine, ISSN 1464-2662, 07/2017, Volume 18, Issue 6, pp. 395 - 401
Objectives The aim of the study was to describe the ageing HIV‐infected population (> 50 years old) and their current antiretroviral therapy (ART),... 
ageing with HIV | comorbidity | drug−drug interactions | polypharmacy | INFECTIOUS DISEASES | RALTEGRAVIR | EFFICACY | DRUG-INTERACTIONS | drug-drug interactions | EFAVIRENZ | DISEASE | INFECTED PATIENTS | COHORT | INTEGRASE INHIBITOR | Prospective Studies | Age Factors | Humans | Middle Aged | HIV Seropositivity - drug therapy | Male | Sex Characteristics | Drug Prescriptions | Comorbidity - trends | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Retrospective Studies | Highly active antiretroviral therapy | Protease inhibitors | Proteases | Comorbidity | Analysis | HIV (Viruses) | HIV infection | Integrase | Drugs | Antiretroviral drugs | Therapy | Receiving | RNA-directed DNA polymerase | Proteinase | Central nervous system | Infections | Patients | Optimization |